Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank

被引:5
作者
Jin, Danyao [1 ,2 ]
Trichia, Eirini [1 ,2 ,3 ]
Islam, Nazrul [1 ,2 ,4 ]
Besevic, Jelena [1 ,2 ,5 ]
Lewington, Sarah [1 ,2 ,3 ]
Ben Lacey [1 ,2 ,5 ]
机构
[1] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford, England
[2] Univ Oxford, Epidemiol Studies Unit, Nuffield Dept Populat Hlth, Oxford, England
[3] Univ Oxford, Med Res Council Populat Hlth Res, Oxford, England
[4] Univ Southampton, Fac Med, Southampton, Hants, England
[5] UK Biobank Stockport, Manchester, England
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 20期
基金
英国科研创新办公室;
关键词
apolipoproteins; cholesterol; coronary heart disease; lipoproteins; nuclear magnetic resonance; triglycerides; UK biobank; MYOCARDIAL-INFARCTION; RISK-FACTOR; LIPIDS; LDL; TRIGLYCERIDES; CHOLESTEROL; APOLIPOPROTEINS; DISCORDANCE; MORTALITY; VARIANTS;
D O I
10.1161/JAHA.123.029552
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Associations of coronary heart disease (CHD) with plasma lipids are well described, but the associations with characteristics of lipoproteins (which transport lipids) remain unclear. METHODS AND RESULTS: UK Biobank is a prospective study of 0.5 million adults. Analyses were restricted to 89 422 participants with plasma lipoprotein and apolipoprotein measures from Nightingale nuclear magnetic resonance spectroscopy and without CHD at baseline. CHD risk was positively associated with concentrations of very-low-density lipoproteins, intermediate-density lipoproteins, and low-density lipoproteins (LDL), and inversely associated with high-density lipoproteins. Hazard ratios (99% CIs) per SD were 1.22 (1.17-1.28), 1.16 (1.11-1.21), 1.20 (1.15-1.25), and 0.90 (0.86- 0.95), respectively. Larger subclasses of very-low-density lipoproteins were less strongly associated with CHD risk, but associations did not materially vary by size of LDL or high-density lipoprotein. Given lipoprotein particle concentrations, lipid composition (including cholesterol) was not strongly related to CHD risk, except for triglyceride in LDL particles. Apolipoprotein B was highly correlated with LDL concentration (r=0.99), but after adjustment for apolipoprotein B, concentrations of very-low-density lipoprotein and high-density lipoprotein particles remained strongly related to CHD risk. CONCLUSIONS: This large-scale study reliably quantifies the associations of nuclear magnetic resonance-defined lipoprotein characteristics with CHD risk. CHD risk was most strongly related to particle concentrations, and separate measurements of lipoprotein concentrations may be of greater value than the measurement by apolipoprotein B, which was largely determined by LDL concentration alone. Furthermore, there was strong evidence of positive association with mean triglyceride molecules per LDL particle but little evidence of associations with total triglycerides or other lipid and lipoprotein fractions after accounting for lipoprotein concentrations.
引用
收藏
页数:11
相关论文
共 37 条
  • [1] High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease
    Akinkuolie, Akintunde O.
    Paynter, Nina P.
    Padmanabhan, Latha
    Mora, Samia
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (01): : 55 - 63
  • [2] Biomarkers of inflammation predict both vascular and non-vascular mortality in older men
    Clarke, Robert
    Emberson, Jonathan R.
    Breeze, Elizabeth
    Casas, Juan P.
    Parish, Sarah
    Hingorani, Aroon D.
    Fletcher, Astrid
    Collins, Rory
    Smeeth, Liam
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (06) : 800 - 809
  • [3] Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
  • [4] Common variants associated with plasma triglycerides and risk for coronary artery disease
    Do, Ron
    Willer, Cristen J.
    Schmidt, Ellen M.
    Sengupta, Sebanti
    Gao, Chi
    Peloso, Gina M.
    Gustafsson, Stefan
    Kanoni, Stavroula
    Ganna, Andrea
    Chen, Jin
    Buchkovich, Martin L.
    Mora, Samia
    Beckmann, Jacques S.
    Bragg-Gresham, Jennifer L.
    Chang, Hsing-Yi
    Demirkan, Ayse
    Den Hertog, Heleen M.
    Donnelly, Louise A.
    Ehret, Georg B.
    Esko, Tonu
    Feitosa, Mary F.
    Ferreira, Teresa
    Fischer, Krista
    Fontanillas, Pierre
    Fraser, Ross M.
    Freitag, Daniel F.
    Gurdasani, Deepti
    Heikkila, Kauko
    Hyppoenen, Elina
    Isaacs, Aaron
    Jackson, Anne U.
    Johansson, Asa
    Johnson, Toby
    Kaakinen, Marika
    Kettunen, Johannes
    Kleber, Marcus E.
    Li, Xiaohui
    Luan, Jian'an
    Lyytikainen, Leo-Pekka
    Magnusson, Patrik K. E.
    Mangino, Massimo
    Mihailov, Evelin
    Montasser, May E.
    Mueller-Nurasyid, Martina
    Nolte, Ilja M.
    O'Connell, Jeffrey R.
    Palmer, Cameron D.
    Perola, Markus
    Petersen, Ann-Kristin
    Sanna, Serena
    [J]. NATURE GENETICS, 2013, 45 (11) : 1345 - +
  • [5] High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
    El Harchaoui, Karim
    Arsenault, Benoit J.
    Franssen, Remco
    Despres, Jean-Pierre
    Hovingh, Kees
    Stroes, Erik S. G.
    Otvos, James D.
    Wareham, Nicholas J.
    Kastelein, John J. P.
    Khaw, Kay-Tee
    Boekholdt, S. Matthijs
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (02) : 84 - U43
  • [6] Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
    Ference, Brian A.
    Kastelein, John J. P.
    Ray, Kausik K.
    Ginsberg, Henry N.
    Chapman, John
    Packard, Chris J.
    Laufs, Ulrich
    Oliver-Williams, Clare
    Wood, Angela M.
    Butterworth, Adam S.
    Di Angelantonio, Emanuele
    Danesh, John
    Nicholls, Stephen J.
    Bhatt, Deepak L.
    Sabatine, Marc S.
    Catapano, Alberico L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (04): : 364 - 373
  • [7] Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
    Ference, Brian A.
    Kastelein, John J. P.
    Ginsberg, Henry N.
    Chapman, John
    Nicholls, Stephen J.
    Ray, Kausik K.
    Packard, Chris J.
    Laufs, Ulrich
    Brook, Robert D.
    Oliver-Williams, Clare
    Butterworth, Adam S.
    Danesh, John
    Smith, George Davey
    Catapano, Alberico L.
    Sabatine, Marc S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (10): : 947 - 956
  • [8] Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
    Fry, Anna
    Littlejohns, Thomas J.
    Sudlow, Cathie
    Doherty, Nicola
    Adamska, Ligia
    Sprosen, Tim
    Collins, Rory
    Allen, Naomi E.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 186 (09) : 1026 - 1034
  • [9] Small dense LDL: An emerging risk factor for cardiovascular disease
    Hirayama, Satoshi
    Miida, Takashi
    [J]. CLINICA CHIMICA ACTA, 2012, 414 : 215 - 224
  • [10] Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
    Holmes, Michael V.
    Millwood, Iona Y.
    Kartsonaki, Christiana
    Hill, Michael R.
    Bennett, Derrick A.
    Boxall, Ruth
    Guo, Yu
    Xu, Xin
    Bian, Zheng
    Hu, Ruying
    Walters, Robin G.
    Chen, Junshi
    Ala-Korpela, Mika
    Parish, Sarah
    Clarke, Robert J.
    Peto, Richard
    Collins, Rory
    Li, Liming
    Chen, Zhengming
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (06) : 620 - 632